AB Science receives Chinese patent protecting masitinib in the treatment of Covid-19 until 2041
19/05/2025 – AB Science today announced that the Chinese Patent Office has issued a patent relating to methods of treating severe acute respiratory syndrome coronavirus 2 infection causing COVID-19